{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:07:15Z","timestamp":1791486435617,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Body<\/jats:title>\n                    <jats:p>This selection of highlights provides commentary on 23 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry, proof-of-concepts, preclinical and early clinical studies using novel radiopharmaceuticals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41181-026-00505-4","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:08Z","timestamp":1791389048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Highlight selection of radiochemistry and radiopharmacy developments by editorial board"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1348-0309","authenticated-orcid":false,"given":"Sarah","family":"Spreckelmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Decristoforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Passchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Duatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart T.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Denkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hendrikx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Seimbille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Perk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Caravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Rijn","family":"Zeevaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pellico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Hussain","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"3","key":"505_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/vetsci3030017","volume":"3","author":"F Adega","year":"2016","unstructured":"Adega F, Borges A, Chaves R. Cat Mammary Tumours: Genetic Models for the Human Counterpart. Veterinary Sci. 2016;3(3):17.","journal-title":"Veterinary Sci"},{"key":"505_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s41181-025-00401-3","volume":"10","author":"P Bhardwaj","year":"2025","unstructured":"Bhardwaj P, Frohner C, Geppert C, Gorges C, Brenner W, Claude G, Spreckelmeyer S. Synthesis and in vitro characterization of [198Au]Auranofin. EJNMMI Radiopharm Chem. 2025;10:71.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"505_CR3","doi-asserted-by":"publisher","first-page":"15690","DOI":"10.1021\/acs.jmedchem.1c00903","volume":"64","author":"GD Bowden","year":"2021","unstructured":"Bowden GD, Stotz S, Kinzler J, Geibel C, Lammerhofer M, Pichler BJ, Maurer A. DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [18F]Talazoparib and its In Vivo Evaluation as a PARP Radiotracer. J Med Chem. 2021;64:15690\u2013701.","journal-title":"J Med Chem"},{"key":"505_CR4","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1021\/acs.inorgchem.5c04390","volume":"65","author":"PLD Cao","year":"2026","unstructured":"Cao PLD, Wu Z, Houson HA, Ngo QT, Lapi SE, Lindsey JS. Preferential Formation and Stability of Copper Porphyrins amidst Other Metals in Dilute Aqueous Solution \u2013 Applications for Radiopharmaceuticals. Inorg Chem. 2026;65:4884\u2013900.","journal-title":"Inorg Chem"},{"key":"505_CR6","doi-asserted-by":"publisher","first-page":"e71652","DOI":"10.1002\/alz.71652","volume":"22","author":"C Ceron","year":"2026","unstructured":"Ceron C, Casquero-Veiga M, Lamanna-Rama N, Fernandez-Nueda I, Fernandez-Pena A, Olazagoitia N, Sobrino G, Herraiz A, Gonzalez MI, Munoz-Hernando M, Ruperti-Repilado A, Romero-Sanz E, Angel Morcillo M, Perez-Medina C, Moro MA, Villaverde G, Rubio J, Fernandez-Ferro J, Desco M, Herranz F, Salinas B, Fuster V, Cortes-Canteli M. Unveiling the procoagulant state in Alzheimer\u2019s disease: A novel PET imaging strategy. Alzheimer\u2019s Dement. 2026;22:e71652.","journal-title":"Alzheimer\u2019s Dement"},{"key":"505_CR7","doi-asserted-by":"publisher","unstructured":"Chu ACK, Ho F, Chan C, Cai Z, Ganga-Sah Y, Randhawa P, et al. Panitumumab labelled with Auger electron-emitting 197gHg\/197mHg: cytotoxicity on human breast cancer cells and tumour and normal tissue uptake in mice with EGFR-overexpressing breast cancer xenografts. EJNMMI Radiopharm Chem. 2026;11. https:\/\/doi.org\/10.1186\/s41181-026-00449-9.","DOI":"10.1186\/s41181-026-00449-9"},{"issue":"3","key":"505_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12149-018-1238-z","volume":"32","author":"HH Coenen","year":"2018","unstructured":"Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, Jeong JM, Mach RH, Mindt TL, Pike VW, Windhorst AD. Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines. Ann Nucl Med. 2018;32(3):236\u20138.","journal-title":"Ann Nucl Med"},{"issue":"8015","key":"505_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","volume":"630","author":"XY Cui","year":"2024","unstructured":"Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, Wang C, Chen J, Xu M, Li Y, Gao J, Zhu W, Hao Z, Huo L, Liu S, Yang Z, Liu Z. Covalent Targeted Radioligands Potentiate Radionuclide Therapy. Nature. 2024;630(8015):206\u201313.","journal-title":"Nature"},{"key":"505_CR10","doi-asserted-by":"publisher","first-page":"112739","DOI":"10.1016\/j.apradiso.2026.112739","volume":"236","author":"C Deville","year":"2026","unstructured":"Deville C, Salek MV, Pedersen KS, Jensen M, Engle JW. Small cyclotron production of non-carrier-added 103Pd from electroplated Rh targets. Appl Radiat Isot. 2026;236:112739.","journal-title":"Appl Radiat Isot"},{"issue":"1","key":"505_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s44303-025-00126-7","volume":"3","author":"K Dvorakova Bendova","year":"2025","unstructured":"Dvorakova Bendova K, Krasulova K, Neuzilova B, Hajduch M, Petrik M. New insights into radiolabelled siderophores for molecular imaging of bacterial infections. Npj Imaging. 2025;3(1):63.","journal-title":"Npj Imaging"},{"issue":"1","key":"505_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41181-019-0063-6","volume":"4","author":"N Gracheva","year":"2019","unstructured":"Gracheva N, M\u00fcller C, Talip Z, Heinitz S, K\u00f6ster U, Zeevaart JR, V\u00f6gele A, Schibli R, van der Meulen NP. Production and characterization of no-carrier-added 161\u00a0Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy. EJNMMI Radiopharm Chem. 2019;4(1):12.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"505_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.2967\/jnumed.125.270083","volume":"67","author":"SA Graves","year":"2026","unstructured":"Graves SA, Bushnell DL, Schultz MK, Jain S, Bodeker KL, Menda Y. A Phase 0 Imaging Trial of [203Pb]Pb-VMT-\u03b1-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [212Pb]Pb-VMT-\u03b1-NET. J Nucl Med. 2026;67:576\u201383.","journal-title":"J Nucl Med"},{"key":"505_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-026-00468-6","author":"A Grundmane","year":"2026","unstructured":"Grundmane A, Ramogida CF, Radchenko V. Recycling-compatible electroplating of enriched tin-119 targets for the production of antimony-119 for targeted Auger electron therapy. EJNMMI Radiopharm Chem. 2026. https:\/\/doi.org\/10.1186\/s41181-026-00468-6.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"505_CR14","doi-asserted-by":"publisher","first-page":"25957","DOI":"10.1021\/jacs.6c04653","volume":"148","author":"Y Guo","year":"2026","unstructured":"Guo Y, Li D, Yang Z, Dong Y, Chen Y, Chen J, Gao S, Shen J, Ning Y. An Iron-Based MRI Probe with Tunable Spin State for Bioorthogonally Catalyzed Activation Imaging. J Am Chem Soc. 2026;148:25957\u201367.","journal-title":"J Am Chem Soc"},{"key":"505_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.1179907","volume":"327","author":"M Hamsell","year":"2010","unstructured":"Hamsell M, Alvarez Y, Xue CD, Robinson, et al. Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation. Science. 2010;327:331\u20134.","journal-title":"Science"},{"issue":"17","key":"505_CR16","doi-asserted-by":"publisher","first-page":"e2391261","DOI":"10.1002\/anie.2391261","volume":"65","author":"MA Joaqui-Joaqui","year":"2026","unstructured":"Joaqui-Joaqui MA, Tran PN, Marlin A, Armstrong-Pavlik F, Cao M, Pierre VC, Boros E. Positron Emission Tomography Imaging of Bacterial Infections With an Enterobactin Analog to Monitor Treatment Efficacy With a Catechol Antibiotic. Angew Chem Int Ed Engl. 2026;65(17):e2391261.","journal-title":"Angew Chem Int Ed Engl"},{"key":"505_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-026-00458-8","author":"TR Johnson","year":"2026","unstructured":"Johnson TR, Lee HB, Guttormsen Y, Mixdorf JC, Barnhart TE, Engle JW, Ellison PA. Scaling the production of bromine-76 and bromine-77 labeled poly-ADP-ribose-polymerase-targeted theranostics for preclinical use. EJNMMI Radiopharm Chem. 2026. https:\/\/doi.org\/10.1186\/s41181-026-00458-8.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"505_CR18","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1021\/acs.molpharmaceut.5c01912","volume":"23","author":"PC Klauser","year":"2026","unstructured":"Klauser PC, Wang L. Covalent radiopharmaceuticals: Precision imaging and therapy for cancer. Mol Pharm. 2026;23:2246\u201355.","journal-title":"Mol Pharm"},{"key":"505_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13046-021-02225-w","volume":"41","author":"AK Kwan","year":"2022","unstructured":"Kwan AK, Piazza GA, Keeton AB, Leite CA. The path to the clinic: a comprehensive review on direct KRAS(G12C) inhibitors. J Exp Clin Cancer Res. 2022;41:27.","journal-title":"J Exp Clin Cancer Res"},{"key":"505_CR20","doi-asserted-by":"publisher","first-page":"109596","DOI":"10.1016\/j.nucmedbio.2025.109596","volume":"152\u2013153","author":"MR Lewis","year":"2026","unstructured":"Lewis MR, Chambers CG, Heidari-Kharaji M, Sikligar K, Yang VA, Schaedler AW, Golzy M, Watkinson LD, Carmack TL, Lunceford JM, Garrett C, Papageorgiou C, Talbott JL, Maitz CA, Bryan JN, Smith CJ. PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer. Nucl Med Biol. 2026;152\u2013153:109596.","journal-title":"Nucl Med Biol"},{"key":"505_CR21","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.1021\/jacs.5c21595","volume":"148","author":"C Liu","year":"2026","unstructured":"Liu C, Zhang S, Chen J, Geng H, Li H, Zhang Z, Lu Q, Xu L, Li J, Zhang H, Wang L, Zhang MR, Wu Y, Wang R, Hu K. Directional Engineering of Cyclic \u03b2-Hairpin Peptides for PET\/CT Imaging of PD-L1. J Am Chem Soc. 2026;148:13021\u201334.","journal-title":"J Am Chem Soc"},{"key":"505_CR22","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-025-61497-4","volume":"16","author":"Y Luan","year":"2025","unstructured":"Luan Y, Wang W, Huang Q, Wang Y, Nussbaumer J, Wang J, Steward A, Roemer-Cassiano SN, Guan Y, Ewers M, Sch\u00f6ll M, Ni R, Li B, Franzmeier N, Xie F. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer\u2019s disease. Nat Comm. 2025;16:6356.","journal-title":"Nat Comm"},{"key":"505_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2967\/jnumed.125.270508","volume":"67","author":"SK Lyashchenko","year":"2026","unstructured":"Lyashchenko SK, Esposito TV, Tran T, Bauer D, Jones K, Park H, Carter LM, Kishore Pillarsetty NV, Lewis JS. Radiolabelling of CHX-A\u2033-DTPA-Antibody Conjugates with [\u2078\u2079Zr]ZrCl\u2084. J Nucl Med. 2026;67:132\u20138.","journal-title":"J Nucl Med"},{"key":"505_CR24","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1021\/acs.jmedchem.5c03486","volume":"69","author":"X Mu","year":"2026","unstructured":"Mu X, Zhang L, Chen Z, Chow HY, Li J, Chong W, Mo Y, Tang G, Li X, Fu W. Structure-Guided Designed 18F-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study. J Med Chem. 2026;69:12941\u201354.","journal-title":"J Med Chem"},{"key":"505_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.6c00253","author":"R Muzzioli","year":"2026","unstructured":"Muzzioli R, Pisaneschi F, Gammon ST, Sutton MN, Napoli A, Puglielli RB, McIntosh L, Tereshatov E, Tabacaru G, Schultz S, McCann L, Burns JD, Yennello S, Piwnica-Worms D. Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy. ACS Chem Biol. 2026. https:\/\/doi.org\/10.1021\/acschembio.6c00253.","journal-title":"ACS Chem Biol"},{"key":"505_CR26","doi-asserted-by":"publisher","first-page":"e22650","DOI":"10.1002\/anie.202522650","volume":"65","author":"IF Ogilvy","year":"2026","unstructured":"Ogilvy IF, Ford J, Ortalli S, Renders E, Hayes TR, Liu S, Mortiers I, Nikolopoulou A, Sorlin AM, Trabanco AA, Tredwell M, Buijnsters PJJA, Salter R. Gouverneur V. 18F-Radiopharmaceutical diversification enables by deaminative cross-electrophile couplings. Angew Chem Int Ed Engl. 2026;65:e22650.","journal-title":"Angew Chem Int Ed Engl"},{"key":"505_CR27","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL. The Frequency of Ras Mutations in Cancer. Cancer Res. 2020;80:2969\u201374.","journal-title":"Cancer Res"},{"key":"505_CR29","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1039\/D5SC08259E","volume":"17","author":"Z Qiu","year":"2026","unstructured":"Qiu Z, Zheng X, Pan S, Zhong Y, Chen X, Wen X, Chen X, Li S, Cheng H, Chen X. Stearic acid-modified PSMA-targeting peptide drug conjugate for long-acting prostate cancer therapy. Chem Sci. 2026;17:8651.","journal-title":"Chem Sci"},{"key":"505_CR28","unstructured":"Radiopharmaceuticals EU-IN. Horizon Scanning Report. Reference Number: MA\/82413\/2026. https:\/\/www.ema.europa.eu\/en\/documents\/report\/radiopharmaceuticals-eu-horizon-scanning-report_en.pdf. Accessed 31-August-2026."},{"issue":"4","key":"505_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1470-2045(26)00017-3","volume":"27","author":"S Sandhu","year":"2026","unstructured":"Sandhu S, Joshua AM, Emmett L, Bressel M, Anton A, Spain L, Horvath LG, Pasam A, Tolmeijer SH, Akhurst TJ, Alipour R, Banks P, Buteau JP, Cassidy E, Crumbaker M, Dhiantravan N, Xu W, Chan J, Hitchen N, Scalzo M, Ravi Kumar AS, Kong G, Wallace R, Williams N, Williams S, Haynes NM, Neeson P, Wyatt AW, Hicks RJ, Hofman MS. [177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b\/2 study. Lancet Oncol. 2026;27(4):470\u20139.","journal-title":"Lancet Oncol"},{"issue":"6","key":"505_CR31","doi-asserted-by":"publisher","first-page":"e015261","DOI":"10.1136\/jitc-2026-015261","volume":"14","author":"D Shim","year":"2026","unstructured":"Shim D, Mouton C, Moseman JE, Comas Rojas H, Jeon D, Idrissou MB, Hernandez R, Weichert JP, McNeel DG. Activation of tumor-specific CD8\u2009+\u2009T cells prior to radiopharmaceutical therapy improves antitumor response. J Immunother Cancer. 2026;14(6):e015261.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"505_CR32","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2967\/jnumed.123.265906","volume":"64","author":"A Signore","year":"2023","unstructured":"Signore A, Ordonez AA, Arjun C, Aulakh GK, Beziere N, Dadachova E, Ebenhan T, Granados U, Korde A, Jalilian A, Lestari W, Mukherjee A, Petrik M, Sakr T, Cuevas CLS, Welling MM, Zeevaart JR, Jain SK, Wilson DM. The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection. J Nucl Med. 2023;64(11):1676\u201382.","journal-title":"J Nucl Med"},{"key":"505_CR33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1021\/acs.bioconjchem.6c00056","volume":"37","author":"A Stoddard","year":"2026","unstructured":"Stoddard A, Furey K, Dehlavi G, Mane MM, Sebastiano J, Zeglis BM. Linker chemistry in radiopharmaceutical design. Bioconjug Chem. 2026;37:630\u201365.","journal-title":"Bioconjug Chem"},{"key":"505_CR34","doi-asserted-by":"publisher","DOI":"10.1039\/d6sc03006h","author":"J Sypniewski","year":"2026","unstructured":"Sypniewski J, Lee YS, Tran P, Costner S, Simeon FG, Pike VW. Triarylselenonium triflates provide efficient access to no-carrier-added ortho-, meta-, and para-[18F]Fluoroarenes. Chem Sci. 2026. https:\/\/doi.org\/10.1039\/d6sc03006h.","journal-title":"Chem Sci"},{"key":"505_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08449-8","author":"T Tago","year":"2026","unstructured":"Tago T, Sakata M, Kamitaka Y, Kameyama M, Ishii K, Toyohara J. First-in-human PETstudy of [18F]FSW-100 for imaginghistone deacetylase 6 in the brain: safety, biodistribution, radiationdosimetry, and brain kinetic analyses. J Transl Med. 2026. https:\/\/doi.org\/10.1186\/s12967-026-08449-8.","journal-title":"J Transl Med"},{"key":"505_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c03527","author":"X Wang","year":"2026","unstructured":"Wang X, Zhang S, Li Y, Liu C, Wu J, Wu Y, Hu Q, Liu W, Lu Q, Hu X, Dai D, Zhang Y, Zhang Z, Wang F, Wang R, Hu K. Design, Synthesis, and Evaluation of 68Ga\/177Lu-Labeled TSPO-Targeting Radioligands for PET\/CT Diagnosis and Radionuclide Therapy of Brain Tumor. J Med Chem. 2026. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03527.","journal-title":"J Med Chem"},{"key":"505_CR37","doi-asserted-by":"crossref","unstructured":"Willmann M, Bankstahl JP, Bengel FM, Drechler C, Esdar C, Glaeser K, Lopez AU, Ross T, Schieferstein H, Ross TL. Development and in vivo evaluation of 18F-labeled PET tracers covalently targeting KRAS-G12C for noninvasive cancer diagnosis and therapy monitoring, Theranostics. 2026;16:6485\u20136496.","DOI":"10.7150\/thno.123741"},{"key":"505_CR38","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1021\/acs.molpharmaceut.6c00367","volume":"23","author":"Y Zheng","year":"2026","unstructured":"Zheng Y, Kong D, Huynh TT, Zhao X, Liu Y, Banks RL, et al. Synthesis and Preliminary Evaluation of the 211At-Labeled PARP Inhibitor [211At]Talazoparib as a Targeted Alpha-Particle Emitting Therapeutic. Mol Pharm. 2026;23:3904\u201315. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00367.","journal-title":"Mol Pharm"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-026-00505-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:03:25Z","timestamp":1791482605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-026-00505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1186\/s41181-026-00505-4","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"7 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any original studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"74"}}